Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidermal growth factor receptor family and chemosensitization.

× No keyword cloud information.

21 in total

Review 1. Molecular therapy in head and neck oncology.

Authors: Jacques Bernier; Søren M Bentzen; Jan B Vermorken
Journal: Nat Rev Clin Oncol Date: 2009-05 Impact factor: 66.675

2. The role of oncogenes in drug resistance.

Authors: D Yu
Journal: Cytotechnology Date: 1998-09 Impact factor: 2.058

3. EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer.

Authors: David E Gerber
Journal: Drug Dev Res Date: 2008-12-09 Impact factor: 4.360

Review 4. Establishing a link between oncogenes and tumor angiogenesis.

Authors: R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal: Mol Med Date: 1998-05 Impact factor: 6.354

5. Effect of cetuximab treatment in squamous cell carcinomas.

Authors: Marika Nestor
Journal: Tumour Biol Date: 2010-02-24

6. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death.

Authors: P Dent; D B Reardon; J S Park; G Bowers; C Logsdon; K Valerie; R Schmidt-Ullrich
Journal: Mol Biol Cell Date: 1999-08 Impact factor: 4.138

7. Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

Authors: C I Sartor; H Zhou; E Kozlowska; K Guttridge; E Kawata; L Caskey; J Harrelson; N Hynes; S Ethier; B Calvo; H S Earp
Journal: Mol Cell Biol Date: 2001-07 Impact factor: 4.272

Review 8. Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy.

Authors: L Vigano; A Locatelli; G Grasselli; L Gianni
Journal: Invest New Drugs Date: 2001-05 Impact factor: 3.850

Review 9. Activated epidermal growth factor receptor in ovarian cancer.

Authors: Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal: Cancer Treat Res Date: 2009

10. MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors: George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal: J Oncol Date: 2009-12-29 Impact factor: 4.375